The World Health Organisation (WHO) is likely to take a call on whether to include Bharat Biotech’s Covid-19 vaccine Covaxin in the emergency use list (EUL) in the next four to six weeks, WHO chief scientist Soumya Swaminathan said.

At a webinar held by the Centre for Science and Environment (CSE) on Friday, she said that the global health body is reviewing Covaxin while its manufacturer Bharat Biotech uploads all the data on the WHO portal.

As per WHO guidelines, emergency use listing (EUL) is a procedure to streamline the process in which new products can be approved and used during public health emergencies like a pandemic.

The World Health Organisation (WHO) is likely to take a call on whether to include Bharat Biotech’s Covid-19 vaccine Covaxin in the emergency use list (EUL) in the next four to six weeks, WHO chief scientist Soumya Swaminathan said.

At a webinar held by the Centre for Science and Environment (CSE) on Friday, she said that the global health body is reviewing Covaxin while its manufacturer Bharat Biotech uploads all the data on the WHO portal.

As per WHO guidelines, emergency use listing (EUL) is a procedure to streamline the process in which new products can be approved and used during public health emergencies like a pandemic.